Abstract:Background and purpose: Peritoneal metastasis of gastric cancer is mainly discovered in the ad-vanced cancer. Nonetheless, the clinical applicability of each tumor biomarker in peritoneal metastasis of gastric cancer is still ambiguous. Therefore, this study investigated the diagnostic value and clinical significance of CEA, CA125 and CA72-4 in gastric carcinoma patients with peritoneal metastases. Methods: A total of 108 gastric carcinoma patients with peritoneal metastases from Jan. 2008 to Dec. 2013 were studied. All patients were diagnosed by imaging, operations and pathological examination, and also received intravenous or intraperitoneal chemotherapy. Serum tumor markers such as CEA, CA125 and CA72-4 were determined during diagnosis and before each chemotherapy. The diagnostic sensitivity of single marker and combined detection with 2 or 3 markers were analyzed. The correlations among the serum tumor markers and clinical pathological factors, chemotherapeutic effects and survival time were analyzed. Results: Positive rates of CEA, CA125 and CA72-4 were 20.4%, 46.3% and 45.4% in gastric cancer patients with peritoneal metastases, respectively. For these patients, the positive rates of CEA/CA125, CEA/CA72-4, CA125/CA72-4 and CEA/CA125/CA72-4 were 54.7%, 52.8%, 69.5% and 79.6%, respectively. The combined detection of 3 tumor markers was much better than single marker detection (P<0.05). Positive rates of CEA, CA125 and CA72-4 were correlated with the ECOG scale (P<0.05). Positive rate of CA125 was associated with ascites (P<0.001), while positive rate of CA72-4 was associated with ovarian metastasis (P<0.05). Median survival time of patients with positive rates of CEA, CA125 and CA72-4 was significantly lower than that of the patients with normal levels of these markers (P<0.05). Compared with pre-treatment, the levels of all three tumor markers significantly declined after three cycles of chemo-therapy (P<0.05). The decline in CA125 level after chemotherapy was significantly correlated with decreased amount of ascites (P<0.05). The tumor markers turned negative after 3 cycles chemotherapy in patients with positive markers upon initial diagnosis, their survival was significantly prolonged (P<0.001). Conclusion: Combined detection of serum CEA, CA125 and CA72-4 can significantly promote diagnostic rate of gastric cancer with peritoneal metastasis, and may be helpful in evaluating chemotherapeutic effects and predicting prognosis.

Real-time RT-PCR and Electrochemistry Immunoassay Detections of CEA in Peritoneal Washes of Gastric Cancer and Its Clinical Significance

Detection of CEA~(··)mRNA in Peritoneal Washings of Gastric Cancer and Its Clinical Significance

Detection of Carcinoembryonic Antigen Mrna in Peritoneal Washes from Gastric Cancer Patients and Its Clinical Significance

Quantitative detection of CEA level in the peritoneal cavity of colorectal carcinoma patients with real-time RT-PCR and Its clinical significance

The Value of CEA Mrna and Cytology in Examination of Peritoneal Washes from Patients with Gastric Cancer

Quantitative Detection of Disseminated Cancer Cells in Peritoneal Washes with Real-Time RT-PCR for Patients with Colorectal Carcinoma and Its Clinical Significance

Detection of STAT3 Mrna and CEA Mrna in Peritoneal Washings for Predicting Peritoneal Micrometastasis in Patients with Gastric Carcinoma

Quantitative Detection of CEA Gene Expression in the Peripheral Blood of Patients with Gastric or Intestinal Cancer by the Method of Real-time RT-PCR.

Prognostic Value of CEA Mrna in the Peritoneal Lavage of Patients Undergoing Curative Surgery for Gastric Cancer.

Clinical significance of CEA and CK20 expression in exfoliated cells by fiberoptic bronchoscopy brushing

Detection of micrometastatic cancer cells in peritoneal cavity of patients with colorectal cancer

[Clinical significance of CEA mRNA detection in pleural and peritoneal effusions by real-time fluorescent quantitative RT-PCR].

Detection of Carcinoembryonic Antigen Messenger Rna in Blood Using Quantitative Real-Time Reverse Transcriptase-Polymerase Chain Reaction to Predict Recurrence of Gastric Adenocarcinoma

Cmar_a_246566 2767..2775

Prognostic Value of the Combination of CEA and Fibrinogen/Albumin Ratio in Resectable Gastric Cancer

Detection of intraperitoneal free cancer cells in gastric cancer patients undergoing gastrectomy and its relationship with short-term prognosis

Molecular Detection of Disseminated Tumor Cells in the Peripheral Blood of Patients with Gastric Cancer: Evaluation of Their Prognostic Significance

Clinical significance of serum CEA, CA125 and CA72-4 in gastric carcinoma with peritoneal metastasis

Detection and application of cell-free nucleic acid biomarkers for diagnosis of gastric cancer

Detection and Clinicopathologic Significance of CK20,CK19,CEA Mrna in Peripheral Blood from Patients with Esophageal Cancer

Detection and quantification of circulating tumor cells in esophageal squamous cancer by real-time fluorescent quantitative reverse transcription-polymerase chain reaction